Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cemtrex (CETXP) Research & Development (2017 - 2025)

Cemtrex filings provide 9 years of Research & Development readings, the most recent being $501435.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 43.66% to $501435.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 42.2% decrease, with the full-year FY2025 number at $2.4 million, down 29.91% from a year prior.
  • Research & Development hit $501435.0 in Q4 2025 for Cemtrex, up from $298603.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.6 million in Q1 2023 to a low of -$627723.0 in Q3 2023.
  • Median Research & Development over the past 5 years was $856644.0 (2023), compared with a mean of $830546.9.
  • Biggest five-year swings in Research & Development: crashed 180.11% in 2023 and later soared 210.36% in 2024.
  • Cemtrex's Research & Development stood at $1.1 million in 2021, then soared by 43.37% to $1.5 million in 2022, then plummeted by 44.82% to $848805.0 in 2023, then grew by 4.86% to $890083.0 in 2024, then plummeted by 43.66% to $501435.0 in 2025.
  • The last three reported values for Research & Development were $501435.0 (Q4 2025), $298603.0 (Q3 2025), and $386565.0 (Q2 2025) per Business Quant data.